Published in J Clin Monit Comput on October 30, 2014
Cardiac output monitoring in severe aortic stenosis: Which technologies are reliable? J Clin Monit Comput (2015) 0.75
Continuous measurement of cardiac output using pulse-contour analysis: truly beat-to-beat? J Clin Monit Comput (2014) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
Stroke volume determination using transcardiopulmonary thermodilution and arterial pulse contour analysis in severe aortic valve disease. Intensive Care Med (2013) 2.85
Continuous cardiac output by femoral arterial thermodilution calibrated pulse contour analysis: comparison with pulmonary arterial thermodilution. Crit Care Med (1999) 2.50
Cardiac output monitoring using indicator-dilution techniques: basics, limits, and perspectives. Anesth Analg (2010) 2.23
Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med (2007) 2.18
A critical review of the ability of continuous cardiac output monitors to measure trends in cardiac output. Anesth Analg (2010) 2.05
Methods of blood pressure measurement in the ICU. Crit Care Med (2013) 1.89
Tracking changes in cardiac output: methodological considerations for the validation of monitoring devices. Intensive Care Med (2009) 1.76
Evaluation of a new continuous thermodilution cardiac output monitor in critically ill patients: a prospective criterion standard study. Crit Care Med (1995) 1.74
Arterial pressure allows monitoring the changes in cardiac output induced by volume expansion but not by norepinephrine. Crit Care Med (2011) 1.61
Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it? Catheter Cardiovasc Interv (2010) 1.57
Cardiac output monitoring: an integrative perspective. Crit Care (2011) 1.32
Anesthesia management for transapical transcatheter aortic valve implantation: a case series. J Cardiothorac Vasc Anesth (2009) 1.25
Can changes in arterial pressure be used to detect changes in cardiac index during fluid challenge in patients with septic shock? Intensive Care Med (2012) 1.13
Beat-to-beat measurement of cardiac output by intravascular pulse contour analysis: a prospective criterion standard study in patients after cardiac surgery. J Cardiothorac Vasc Anesth (2000) 1.09
Validity of an arterial pressure waveform analysis device: does the puncture site play a role in the agreement with intermittent pulmonary artery catheter thermodilution measurements? J Cardiothorac Vasc Anesth (2009) 0.96
Evaluation of the accuracy and response time of STAT-mode continuous cardiac output. J Cardiothorac Vasc Anesth (1997) 0.91
Continuous cardiac output catheters: delay in in vitro response time after controlled flow changes. Anesthesiology (1998) 0.84
Neurohumoral changes during onset and offset of ovine heart failure: role of ANP. Am J Physiol (1989) 0.84
Delayed time response of the continuous cardiac output pulmonary artery catheter. Anesth Analg (1996) 0.83
Acute improvement in arterial-ventricular coupling after transcatheter aortic valve implantation (CoreValve) in patients with symptomatic aortic stenosis. Int J Cardiovasc Imaging (2011) 0.82
Response time of different methods of cardiac output monitoring during cardiopulmonary resuscitation and recovery. J Cardiothorac Vasc Anesth (2009) 0.81
Pulse contour cardiac output monitoring during a complicated percutaneous aortic valve replacement. J Cardiothorac Vasc Anesth (2009) 0.81
The accuracy and responsiveness of continuous noninvasive arterial pressure during rapid ventricular pacing for transcatheter aortic valve replacement. Anesth Analg (2013) 0.79
Thermal filament continuous thermodilution cardiac output delayed response limits its value during acute hemodynamic instability. J Trauma (1999) 0.79
Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure. Circ Heart Fail (2012) 0.78
Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med (2009) 6.62
Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. N Engl J Med (2013) 5.29
Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2010) 3.79
Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science (2002) 3.13
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol (2013) 2.97
Stroke volume determination using transcardiopulmonary thermodilution and arterial pulse contour analysis in severe aortic valve disease. Intensive Care Med (2013) 2.85
Stroke volume variations for assessment of cardiac responsiveness to volume loading in mechanically ventilated patients after cardiac surgery. Intensive Care Med (2002) 2.73
Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA (2011) 2.61
Polyclonal long-term repopulating stem cell clones in a primate model. Blood (2002) 2.53
Influence of tidal volume on left ventricular stroke volume variation measured by pulse contour analysis in mechanically ventilated patients. Intensive Care Med (2003) 2.23
Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development (2006) 2.20
Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J (2010) 2.14
Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. Eur J Cardiothorac Surg (2013) 2.01
Radial Artery Applanation Tonometry for Continuous Noninvasive Cardiac Output Measurement: A Comparison With Intermittent Pulmonary Artery Thermodilution in Patients After Cardiothoracic Surgery. Crit Care Med (2015) 2.00
Reliability of a new algorithm for continuous cardiac output determination by pulse-contour analysis during hemodynamic instability. Crit Care Med (2002) 1.99
One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2011) 1.98
MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail (2011) 1.95
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94
Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A (2004) 1.87
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol (2003) 1.85
Myeloperoxidase attracts neutrophils by physical forces. Blood (2010) 1.84
Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol (2010) 1.75
Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions. Catheter Cardiovasc Interv (2013) 1.58
The impact of early goal-directed fluid management on survival in an experimental model of severe acute pancreatitis. Intensive Care Med (2013) 1.51
Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk. Eur J Cardiothorac Surg (2011) 1.51
Goal-directed fluid management reduces vasopressor and catecholamine use in cardiac surgery patients. Intensive Care Med (2006) 1.49
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med (2010) 1.49
Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses. J Thorac Cardiovasc Surg (2011) 1.48
Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther (2006) 1.47
Thermodilution-derived indices for assessment of left and right ventricular cardiac function in normal and impaired cardiac function. Crit Care Med (2011) 1.47
An externalized transseptal guidewire technique to facilitate guidewire stabilization and stent-graft passage in the aortic arch. J Endovasc Ther (2010) 1.47
Heart-lung interactions measured by electrical impedance tomography. Crit Care Med (2011) 1.43
Anaesthesia or sedation for MRI in children. Curr Opin Anaesthesiol (2010) 1.42
Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus. Eur J Cardiothorac Surg (2012) 1.42
Simultaneous mapping of activation and motion timing in the healthy and chronically ischemic heart. Heart Rhythm (2006) 1.41
Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency. Europace (2013) 1.41
Tetrastarch sustains pulmonary microvascular perfusion and gas exchange during systemic inflammation. Crit Care Med (2012) 1.40
Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort. Catheter Cardiovasc Interv (2014) 1.39
The influence of cardiac preload and positive end-expiratory pressure on the pre-ejection period. Physiol Meas (2005) 1.39
Usefulness of left ventricular stroke volume variation to assess fluid responsiveness in patients with reduced cardiac function. Crit Care Med (2003) 1.39
Transseptal and transmitral Parachute® implantation in conjunction with "MitraClipping". EuroIntervention (2015) 1.38
First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal (2008) 1.34
Inflammatory pathways underlying atrial fibrillation. Trends Mol Med (2011) 1.23
Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. Free Radic Biol Med (2004) 1.22
Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit: a prospective, randomized controlled trial. Anesthesiology (2013) 1.21
Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg (2012) 1.20
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arterioscler Thromb Vasc Biol (2006) 1.17
The effect of detailed, video-assisted anesthesia risk education on patient anxiety and the duration of the preanesthetic interview: a randomized controlled trial. Anesth Analg (2008) 1.16
PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II). Eur J Cardiothorac Surg (2012) 1.16
Perioperative fluid and volume management: physiological basis, tools and strategies. Ann Intensive Care (2011) 1.15
Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes. Eur J Cardiothorac Surg (2012) 1.15
Successful resection of a symptomatic right ventricular lipoma. Ann Thorac Surg (2003) 1.12
Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg (2010) 1.09
Patient monitoring alarms in the ICU and in the operating room. Crit Care (2013) 1.09
Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2010) 1.08
The wolf is crying in the operating room: patient monitor and anesthesia workstation alarming patterns during cardiac surgery. Anesth Analg (2010) 1.06
Colloidal gold particles as a new in vivo marker of early acute lung injury. Am J Physiol Lung Cell Mol Physiol (2004) 1.04
Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol (2003) 1.04
Cardiac index measurements during rapid preload changes: a comparison of pulmonary artery thermodilution with arterial pulse contour analysis. J Clin Anesth (2005) 1.04
Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol (2014) 1.04
Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol (2007) 1.04
Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxid Redox Signal (2012) 1.04
Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention (2013) 1.03
Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol (2013) 1.03
Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. Oncogene (2002) 1.01
Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniques. Ann Thorac Surg (2005) 1.01
Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. JACC Cardiovasc Interv (2012) 1.00